Can a Common Antidepressant Treat Long COVID Fatigue?
A global clinical trial has identified fluvoxamine, a widely available antidepressant, as a potential treatment for persistent fatigue in patients with long COVID. According to findings published in the Annals of Internal Medicine, the medication demonstrated a 99 percent probability of being more effective than a placebo in reducing exhaustion and improving quality of life … Read more